DUBLIN–(BUSINESS WIRE)–The “Cell Culture Media Market by Type (Serum-Free (CHO, BHK, Vero Cells), Stem Cells, Chemically Defined, Conventional, Specialty), Application (Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User ( pharma, biotech) – Global forecasts to 2026″ report has been added to from ResearchAndMarkets.com offer.
The global cell culture media market is expected to reach USD 10.3 billion by 2026, from USD 4.9 billion in 2021, growing at a CAGR of 16.0% between 2021 and 2026.
The growth of this market is mainly driven by increasing awareness of the benefits of cell-based vaccines, increasing demand for monoclonal antibodies (mAbs), cell research funding, stem cell research growth, launch new cell culture media. by market players and the growing importance given to personalized medicine. On the other hand, the high cost of cell biology research is holding back the growth of this market.
Serum-free media segment accounted for the highest growth rate in the cell culture media market, by type, during the forecast period
In 2020, the serum-free media segment accounted for the largest market share. This can be attributed to the advantages of serum-free media over other types of media, including consistent performance, increased growth and productivity, better control of physiological reactivity, and reduced risk of contamination with adventitious agents transmitted through the bloodstream. serum in cell culture.
Thermo Fisher Scientific, Inc. (USA), Merck KGaA (Germany), Danaher Corporation (USA), Sartorius AG (Germany), Corning Incorporated (USA), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (USA), MiltenyiBiotec (Germany), HiMedia Laboratories Pvt. ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (USA), Cell Applications, Inc. (USA) are some of the key players operating in the cell culture media market.
Asia-Pacific: The fastest growing region in the cell culture media market
The cell culture media market is segmented into North America, Europe, Asia-Pacific, Latin America (LATAM), and Middle East and Africa (MEA). The Asia-Pacific market is expected to register the highest CAGR of 17.5% during the forecast period. The growing geriatric population, favorable regulatory guidelines, government support for the production of cell culture-based vaccines, low manufacturing costs, and the growing focus of global market players on emerging Asian economies are the major drivers. contributing to the cell culture media market growth in Asia-Pacific.
Market dynamics
Drivers
-
Increase in R&D spending in pharmaceutical companies
-
Emerging cell culture technologies for cell-based vaccines
-
Growing demand for monoclonal antibodies
-
Growth of stem cell research
-
Launch of new cell culture media products by market players
-
Growing focus on personalized medicine
Constraints
-
Expensive cell biology research products
-
Ethical concerns about cell biology research
Opportunities
-
Advances in 3D cell culture
-
Increased incidence of infectious diseases and outbreaks of pandemics
-
Emerging Markets
Challenges
-
Survival of small players and new entrants
Companies cited
-
Akron Biotech
-
Athena Environmental Sciences, Inc.
-
Becton, Dickinson and company (comics)
-
Biologos LLC.
-
Biowest SAS
-
Caisson Laboratories Inc.
-
Cellular Applications, Inc.
-
Cellular Biologics, Inc.
-
Cellular Technology Limited LLC.
-
Corning Incorporated
-
Cyagen Biosciences
-
Danaher Corporation
-
Fujifilm Irvine Scientific, Inc. (acquired by Fujifilm Holdings Corporation)
-
Himedia Laboratories Pvt. ltd.
-
Invivogenic
-
Lonza Group AG
-
Merck KGaA
-
Miltenyi Biotec
-
Pan Biotech GmbH
-
Peprotech, Inc.
-
Promocell GmbH
-
Sartorius AG
-
Stemcell Technologies Inc.
-
ThermoFisher Scientific, Inc.
-
Zen-Bio, Inc.
For more information on this report, visit https://www.researchandmarkets.com/r/pkrovy
